Aptus Capital Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$251K Buy
+633
New +$180K ﹤0.01% 1017
2026
Q1
Sell
-1,146
Closed -$294K 1729
2025
Q4
$294K Sell
1,146
-52
-4% -$13.6K ﹤0.01% 892
2025
Q3
$312K Sell
1,198
-145
-11% -$38.1K ﹤0.01% 831
2025
Q2
$328K Buy
1,343
+385
+40% +$96K ﹤0.01% 798
2025
Q1
$253K Buy
958
+99
+12% +$26.8K ﹤0.01% 814
2024
Q4
$218K Buy
859
+92
+12% +$24.7K ﹤0.01% 871
2024
Q3
$243K Buy
767
+29
+4% +$10.3K ﹤0.01% 715
2024
Q2
$276K Sell
738
-1
-0.1% -$338 ﹤0.01% 639
2024
Q1
$256K Buy
739
+204
+38% +$77.3K ﹤0.01% 672
2023
Q4
$245K Sell
535
-30
-5% -$14.8K 0.01% 502
2023
Q3
$275K Buy
+565
New +$266K 0.01% 493
2023
Q1
Sell
-2,974
Closed -$1.52M 836
2022
Q4
$1.52M Buy
+2,974
New +$1.56M 0.05% 236

Other funds holding HUM

Aptus Capital Advisors's HUM Position: Q2 2026 in Review

Aptus Capital Advisors opened a new position in Humana (HUM) in Q2 2026: 633 shares worth $251K. The stake represents ﹤0.01% of the portfolio and ranks #1017 among its holdings. This is a return to the name: Aptus Capital Advisors previously reported a position in HUM as recently as Q4 2025.

Aptus Capital Advisors first reported a position in HUM in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.52M in Q4 2022. 925 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Aptus Capital Advisors held 633 shares of Humana worth $251K as of Q2 2026.
  • Humana was a new Aptus Capital Advisors position in Q2 2026.
  • Humana made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #1017 holding.
  • Aptus Capital Advisors first reported a position in Humana in Q4 2022 and has held it in 12 quarters since.
  • Aptus Capital Advisors's Humana position peaked at $1.52M in Q4 2022.
  • 925 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.